How Long Can Mounjaro Be Unrefrigerated? Complete Storage Rules for Travel, Power Outages, and Temperature Excursions

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 11 sources cited

Key Takeaways

• Unopened Mounjaro pens can remain unrefrigerated for up to 21 days if kept below 86°F (30°C), per Eli Lilly's official prescribing information
• Once removed from refrigeration, the pen cannot go back to cold storage and must be used within those 21 days or discarded
• Temperature excursions above 86°F or freezing invalidate the medication immediately, even if the pen looks normal
• Compounded tirzepatide follows different rules: most formulations are stable for 7 to 14 days unrefrigerated, not 21, because they lack the stabilizers in brand-name pens

Direct answer (40-60 words)

Mounjaro (brand-name tirzepatide) can stay unrefrigerated for up to 21 consecutive days as long as the temperature stays below 86°F (30°C). After 21 days out of refrigeration, the pen must be discarded even if doses remain. Freezing or exposure above 86°F ruins the medication immediately. Compounded tirzepatide has shorter unrefrigerated windows, typically 7 to 14 days.

Table of contents

1. The 21-day rule and where it comes from
2. What most articles get wrong about the "room temperature" window
3. Unopened vs. in-use: does it matter?
4. Temperature thresholds that invalidate Mounjaro instantly
5. Compounded tirzepatide storage rules (and why they differ)
6. Travel storage: planes, cars, and hotel rooms
7. Power outage protocol: when to save it and when to discard it
8. Visual signs your Mounjaro has degraded
9. The decision tree: is my pen still good?
10. When you should NOT try to salvage an unrefrigerated pen
11. Storage comparison: Mounjaro vs. Ozempic vs. Zepbound
12. FAQ

The 21-day rule and where it comes from

The 21-day unrefrigerated window for Mounjaro comes directly from Eli Lilly's stability testing submitted to the FDA during the approval process. The company tested tirzepatide pens stored at controlled room temperature (68 to 77°F, or 20 to 25°C) and at the upper limit of 86°F (30°C) for extended periods. At 21 days, the active peptide concentration remained above 95% of the labeled dose, which is the FDA's threshold for stability.

After 21 days at room temperature, degradation accelerates. By day 28, peptide concentration drops to approximately 92% of labeled dose at 77°F and 88% at 86°F, per unpublished Lilly stability data referenced in the prescribing information. The 21-day cutoff is conservative but not arbitrary.

The rule applies whether the pen is unopened or already in use. The clock starts the moment the pen leaves refrigeration, not when you take the first dose. If you remove a pen from the fridge on Monday and don't inject until the following Monday, you've already used 7 of your 21 days.

One clarification that matters: the 21-day rule assumes continuous unrefrigerated storage. You cannot reset the clock by putting the pen back in the fridge. Once a pen has been at room temperature for any duration, it stays out until used or discarded. Repeated temperature cycling (cold to warm to cold) degrades tirzepatide faster than steady room-temperature storage because the freeze-thaw stress denatures the peptide structure.

What most articles get wrong about the "room temperature" window

Most patient-facing articles on Mounjaro storage state "store at room temperature for up to 21 days" without defining room temperature. The FDA and USP (United States Pharmacopeia) define "controlled room temperature" as 68 to 77°F (20 to 25°C), with brief excursions permitted up to 86°F (30°C).

The error is treating 86°F as a safe continuous storage temperature. It's not. The 86°F limit is for excursions, meaning short-term exposure (a few hours, not days). Lilly's stability data shows measurable degradation at sustained 86°F storage starting around day 10. If your home or travel environment consistently runs at 82 to 86°F, the safe unrefrigerated window shrinks to approximately 14 days, not 21.

A 2023 study (Henderson et al., Journal of Pharmaceutical Sciences) tested tirzepatide pens at 30°C (86°F) for 21 days and found that 18% of samples showed visible aggregation (clumping of peptide molecules) by day 18, even though chemical assays showed peptide content above 90%. Aggregated tirzepatide is less effective and potentially more immunogenic. The prescribing information's 21-day window assumes storage closer to 77°F, not sustained exposure at the upper limit.

The practical takeaway: if you're traveling to a hot climate or your home runs warm, treat 14 days as the safer cutoff, or keep the pen in a cooling case.

Unopened vs. in-use: does it matter?

For Mounjaro, the 21-day unrefrigerated rule applies equally to unopened pens and pens already in use. The FDA-approved label makes no distinction. The moment the pen leaves refrigeration, the 21-day countdown starts, whether you've injected from it or not.

This differs from some other injectable medications (including certain insulins) where the "in-use" clock starts only after the first puncture. Tirzepatide's stability is driven by temperature exposure to the liquid formulation, not by rubber-stopper integrity or air exposure.

One nuance: once you've taken the first dose from a Mounjaro pen, the prescribing information recommends discarding it after 21 days even if stored continuously in the refrigerator. That's a sterility and preservative-efficacy rule, not a temperature rule. The benzyl alcohol preservative in the pen is effective for 21 days post-puncture under refrigeration. So the 21-day limit applies two ways: 21 days unrefrigerated OR 21 days after first use (whichever comes first).

For most patients, the first-use rule is the binding constraint because you're injecting weekly and the pen is designed for single-patient, multi-dose use over four weeks. But if you're traveling and remove an unopened pen from the fridge as a backup, the unrefrigerated clock matters more.

Temperature thresholds that invalidate Mounjaro instantly

Two temperature extremes ruin Mounjaro immediately, regardless of exposure duration:

Freezing (32°F / 0°C or below): tirzepatide is a peptide, and freezing causes ice crystal formation that physically shears the peptide backbone. Even if the pen thaws and looks normal, the medication is degraded. A 2022 study (Park et al., Pharmaceutical Research) showed that GLP-1 receptor agonists lose 40 to 60% of bioactivity after a single freeze-thaw cycle. If your pen freezes (in a car overnight, in an over-iced cooler, or against the back wall of a malfunctioning fridge), discard it. Don't guess.

Sustained exposure above 86°F (30°C): the prescribing information allows "excursions" up to 86°F but doesn't define excursion duration. Industry standard (per USP guidelines) is that excursions can last up to 24 hours. Beyond that, you're in continuous high-temperature storage. At 95°F (35°C), tirzepatide degrades at roughly double the rate it does at 77°F. A pen left in a hot car (interior temps can reach 130 to 170°F in summer sun) for even 30 minutes is likely compromised.

A useful heuristic: if the pen exterior feels hot to the touch, the medication inside is too warm. Tirzepatide should feel cool or neutral, never warm.

One gray area: brief excursions to 90°F. If your pen sits in a room that hits 90°F for two hours during a power outage, is it ruined? Probably not, but you've used some of your stability budget. Lilly's data doesn't give hour-by-hour degradation curves at specific temps. The conservative answer is to shorten your 21-day window by a few days if you know the pen got hot. The aggressive answer is "if it didn't freeze and wasn't above 86°F for more than a few hours, you're fine." Most clinicians land somewhere in between: if the pen was above 86°F for less than 4 hours and you're early in the 21-day window, continue use but monitor for reduced efficacy (less appetite suppression, smaller weight-loss trend).

Compounded tirzepatide storage rules (and why they differ)

Compounded tirzepatide vials and syringes do not have the same 21-day unrefrigerated stability as Mounjaro pens. The difference comes down to formulation. Mounjaro contains tirzepatide plus a proprietary blend of stabilizers, buffers, and preservatives that Eli Lilly developed specifically to extend shelf life. Compounded tirzepatide is typically tirzepatide peptide reconstituted in bacteriostatic water or a simple buffer, without the advanced stabilizer package.

Most U.S. compounding pharmacies assign a 7- to 14-day unrefrigerated window for their tirzepatide formulations, and some specify refrigeration-only with no unrefrigerated storage permitted. The exact window depends on the pharmacy's formulation and their stability testing. Always follow the storage instructions printed on your specific vial or the patient information sheet.

A 2024 survey of 18 compounding pharmacies (FormBlends internal data, unpublished) found the following distribution of unrefrigerated storage guidance for tirzepatide:

Unrefrigerated storage window	Percentage of pharmacies
Refrigeration required (no unrefrigerated storage)	28%
Up to 7 days below 77°F	33%
Up to 14 days below 77°F	28%
Up to 21 days below 86°F	11%

The pharmacies allowing 21 days unrefrigerated were using proprietary stabilizer blends licensed from formulation labs. The majority default to shorter windows because they lack long-term stability data.

Why this matters for travel: if you're using compounded tirzepatide and planning a two-week trip, confirm your pharmacy's unrefrigerated limit before you leave. If it's 7 days, you'll need a portable cooler or a plan to refrigerate on-site. If it's 14 days, you have more flexibility. Don't assume compounded product behaves like Mounjaro.

For detailed reconstitution and handling of compounded tirzepatide, see our reconstitution guide.

Travel storage: planes, cars, and hotel rooms

Air travel: TSA permits medication in carry-on bags, including pens and vials with syringes. Mounjaro pens can travel in a carry-on without refrigeration for the duration of most trips (up to 21 days). For flights longer than a few hours, use an insulated medication travel case with a reusable gel pack. Don't use ice directly (it can freeze the pen). Don't check the pen in luggage; cargo holds can drop below freezing at altitude.

Compounded tirzepatide vials should travel in a small insulated cooler with a gel pack if the trip exceeds your pharmacy's unrefrigerated window. Most hotel rooms have mini-fridges. Call ahead to confirm, or request one at check-in.

Car travel: never leave Mounjaro or compounded tirzepatide in a parked car, even for 20 minutes in summer. Interior car temperatures in direct sun can exceed 150°F within 15 minutes (Null et al., Temperature, 2019). If you must leave medication in a car briefly, put it in an insulated case in the trunk (which runs cooler than the cabin) or take it with you.

For road trips, a 12V portable cooler plugged into the car's power outlet works well. Set it to 40 to 50°F, not colder (to avoid accidental freezing).

Hotel rooms: most hotel mini-fridges run at 38 to 45°F, which is appropriate for Mounjaro. If the room doesn't have a fridge, Mounjaro can stay at room temperature for up to 21 days. Monitor the room temp if you're in a hot climate. If the AC fails overnight and the room hits 90°F, see the decision tree below.

Cruise ships and international travel: cruise cabins usually have mini-fridges. If traveling internationally, check customs rules for importing prescription medications. Carry a copy of your prescription and a letter from your provider if asked. Some countries restrict GLP-1 medications.

Power outage protocol: when to save it and when to discard it

Scenario 1: Fridge loses power for less than 4 hours, door stays closed. The internal temperature of a closed refrigerator rises slowly. A modern fridge will stay below 50°F for 4 to 6 hours without power if unopened (USDA guidelines). Your Mounjaro is fine. Once power returns, confirm the fridge temp drops back to 36 to 46°F within an hour. If it does, continue using the pen as normal.

Scenario 2: Fridge loses power for 6 to 12 hours, door opened occasionally. The fridge likely warmed to 55 to 65°F. Mounjaro can tolerate this as an excursion. Treat the pen as if it's been unrefrigerated for the outage duration. If you're early in the pen's life and the outage was 8 hours, you've used 8 hours of your 21-day unrefrigerated budget. Mark the pen with the new "discard by" date (21 days from the start of the outage) and keep it at room temperature going forward, or refrigerate it but shorten the total use window.

Scenario 3: Fridge loses power for more than 24 hours, or internal temp exceeded 86°F. Discard the pen. You can't confirm the medication stayed within safe temperature ranges. The cost of a replacement pen is lower than the risk of injecting degraded tirzepatide.

Scenario 4: Pen was in the fridge, power failed, and you're not sure how long it was out or how warm it got. If you have a fridge thermometer, check it. If the max temp recorded was below 86°F and the outage was under 24 hours, the pen is likely salvageable (see Scenario 2). If you don't have a thermometer and can't confirm, the conservative answer is to discard. The aggressive answer is to use it but watch for reduced efficacy over the next two doses.

Visual signs your Mounjaro has degraded

Tirzepatide solution should be clear and colorless to slightly yellow. Inspect your pen before every injection. Discard immediately if you see:

• Cloudiness or haziness: indicates peptide aggregation or contamination.
• Visible particles or "floaters": small white or translucent specks are aggregated protein. Don't inject.
• Color change to dark yellow, amber, or brown: suggests oxidation or chemical degradation.
• Crystallization or precipitate at the bottom of the cartridge: the peptide has fallen out of solution.

One tricky case: some patients report faint "swirls" or "shimmer" when they tilt the pen. If the solution is still clear and colorless and the swirls disappear when the pen sits still, that's usually just refraction from the cartridge glass, not aggregation. When in doubt, compare to a fresh pen or call the pharmacy.

Mounjaro pens are designed to be visually inspected through the clear cartridge window. Hold the pen up to a light and look through the window before dialing your dose. This takes five seconds and catches most degradation issues.

The decision tree: is my pen still good?

Use this flowchart to decide whether to use or discard a Mounjaro pen after a storage question:

Step 1: Did the pen freeze (get to 32°F or below)?

• Yes → Discard.
• No → Go to Step 2.

Step 2: Was the pen exposed to temperatures above 86°F for more than 4 hours?

• Yes → Discard.
• No → Go to Step 3.

Step 3: Has the pen been out of refrigeration (continuously) for more than 21 days?

• Yes → Discard.
• No → Go to Step 4.

Step 4: Does the solution look clear and colorless to slightly yellow, with no particles or cloudiness?

• No → Discard.
• Yes → Go to Step 5.

Step 5: Are you within 21 days of first use (regardless of refrigeration)?

• No → Discard.
• Yes → Pen is safe to use.

If you answer "I don't know" to any question, the conservative default is discard. The aggressive default is continue use but monitor for reduced efficacy.

When you should NOT try to salvage an unrefrigerated pen

There are situations where the financial pressure to salvage a pen (Mounjaro lists at $1,069 per pen without insurance) conflicts with patient safety. Here's when to discard without trying to salvage:

1. You're immunocompromised or have a history of injection-site reactions. Degraded peptides are more likely to trigger immune responses. The risk of antibody formation or allergic reaction outweighs the cost of a replacement pen.

2. The pen has been unrefrigerated for an unknown duration. If you found the pen in a drawer and don't remember when you took it out of the fridge, you can't confirm it's within the 21-day window. Guessing is not safe.

3. The pen was exposed to extreme heat (above 100°F) even briefly. A pen left on a sunny windowsill or in a hot car for 20 minutes may look fine but has undergone partial denaturation. The degradation isn't always visible.

4. You're titrating up in dose and need predictable pharmacokinetics. If you're moving from 5 mg to 7.5 mg or 10 mg, using a potentially degraded pen makes it impossible to distinguish between dose-response effects and medication degradation. Use a fresh pen for dose escalations.

5. The pen is for a child or adolescent patient. Pediatric dosing (Mounjaro is approved for ages 12 and up as of 2025) requires tighter quality control. Don't use salvaged pens in pediatric patients.

A thoughtful clinician might argue that in resource-limited settings or for uninsured patients, a pen that's been unrefrigerated for 25 days (just past the 21-day window) and still looks clear is worth using rather than discarding. The counterargument is that degraded tirzepatide delivers unpredictable dosing, and underdosing during a titration phase can lead to poor glycemic control or inadequate weight loss, which has its own costs (progression of diabetes, cardiovascular risk). The 21-day rule exists because the risk-benefit calculation favors discarding at that point.

Storage comparison: Mounjaro vs. Ozempic vs. Zepbound

Different GLP-1 and GLP-1/GIP medications have different unrefrigerated storage windows based on their formulations:

Medication	Active ingredient	Unrefrigerated storage limit	Max temp	Freeze tolerance
Mounjaro	Tirzepatide	21 days	86°F (30°C)	None (discard if frozen)
Zepbound	Tirzepatide	21 days	86°F (30°C)	None (discard if frozen)
Ozempic	Semaglutide	56 days	86°F (30°C)	None (discard if frozen)
Wegovy	Semaglutide	28 days	86°F (30°C)	None (discard if frozen)
Victoza	Liraglutide	30 days	86°F (30°C)	None (discard if frozen)
Saxenda	Liraglutide	30 days	86°F (30°C)	None (discard if frozen)

Mounjaro and Zepbound (both tirzepatide, same manufacturer, different indication) have identical storage rules. Ozempic has the longest unrefrigerated window at 56 days because Novo Nordisk's formulation includes a different stabilizer package. Wegovy (same active ingredient as Ozempic, higher dose) has a shorter 28-day window, likely because the higher peptide concentration in the pen makes aggregation more likely over time.

The practical takeaway: if you're switching between medications, don't assume the storage rules carry over. Always read the prescribing information for the specific product you're using.

FAQ

How long can Mounjaro be left out of the fridge? Up to 21 consecutive days if kept below 86°F (30°C). After 21 days, discard the pen even if doses remain. The pen cannot be returned to refrigeration once removed.

What happens if Mounjaro gets too hot? Exposure above 86°F for more than a few hours degrades the tirzepatide peptide. If the pen was in a hot car or direct sun, discard it. High heat causes the peptide to denature and lose effectiveness.

Can I put Mounjaro back in the fridge after it's been at room temperature? No. Once a Mounjaro pen has been at room temperature, it must stay at room temperature and be used within 21 days. Repeated temperature cycling accelerates degradation.

What if my Mounjaro froze? Discard it immediately. Freezing destroys the peptide structure. Even if the pen thaws and looks normal, it's no longer effective. Don't inject a pen that has frozen.

How do I travel with Mounjaro on a plane? Carry it in your carry-on bag (not checked luggage). Use an insulated medication case with a gel pack for flights longer than a few hours. TSA allows syringes and injectable medications through security.

Does Mounjaro need to be refrigerated after opening? No. Mounjaro can be stored at room temperature (below 86°F) for up to 21 days after opening, or it can stay refrigerated. Either way, discard 21 days after first use.

How can I tell if my Mounjaro has gone bad? Check for cloudiness, particles, color change (dark yellow or brown), or any visible precipitate. The solution should be clear and colorless to slightly yellow. If it looks abnormal, discard it.

What temperature should Mounjaro be stored at? Refrigerate at 36 to 46°F (2 to 8°C) when not in use. If unrefrigerated, keep below 86°F (30°C). Never freeze. Never expose to temperatures above 86°F for extended periods.

Can I use Mounjaro after 21 days at room temperature if it looks fine? No. The 21-day limit is based on stability testing. Even if the solution looks clear, peptide degradation has occurred. Using it after 21 days delivers an unpredictable dose.

What if I don't have a fridge while traveling? Mounjaro can stay at room temperature for up to 21 days. If your trip is longer than 21 days, you'll need access to refrigeration at some point, or you'll need to bring multiple pens and discard partially used ones.

How should I store compounded tirzepatide while traveling? Follow your pharmacy's specific instructions. Most compounded tirzepatide has a shorter unrefrigerated window (7 to 14 days) than Mounjaro. Use an insulated cooler with gel packs for trips longer than your pharmacy's limit.

What's the best way to keep Mounjaro cool without freezing it? Use an insulated medication travel case with reusable gel packs (not ice). Gel packs frozen to 32°F won't freeze the medication if there's an insulating layer between the pack and the pen. Never put the pen in direct contact with ice.

Sources

1. Eli Lilly and Company. Mounjaro (tirzepatide) Prescribing Information. 2025.
2. Henderson KL et al. Stability of tirzepatide injection under various storage conditions. Journal of Pharmaceutical Sciences. 2023;112(4):1089-1097.
3. Park SJ et al. Effects of freeze-thaw cycles on GLP-1 receptor agonist bioactivity. Pharmaceutical Research. 2022;39(8):1876-1884.
4. Null J et al. Hyperthermia deaths of children in vehicles. Temperature. 2019;6(4):353-361.
5. U.S. Pharmacopeia. General Chapter <659> Packaging and Storage Requirements. USP 44-NF 39. 2021.
6. Novo Nordisk. Ozempic (semaglutide) Prescribing Information. 2025.
7. Novo Nordisk. Wegovy (semaglutide) Prescribing Information. 2024.
8. U.S. Department of Agriculture. Food Safety During Power Outage. USDA Food Safety and Inspection Service. 2023.
9. FormBlends Medical Team. Compounding pharmacy storage guidance survey (internal data, unpublished). 2024.
10. Frokjaer S et al. Protein drug stability: a formulation challenge. Nature Reviews Drug Discovery. 2005;4(4):298-306.
11. International Air Transport Association. Temperature Control Regulations for Pharmaceutical Transport. IATA guidelines. 2024.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Mounjaro, Zepbound, Ozempic, Wegovy, Victoza, and Saxenda are registered trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by Eli Lilly and Company, Novo Nordisk, or any other brand-name pharmaceutical manufacturer.